{
  "dataset_name": "Expanded_Calibration_Set_v3.1.1_MetaLearning",
  "version": "3.1.1-meta",
  "description": "Enhanced calibration set with glycan-aware meta-learning, site value weighting, and mechanism-specific strategies. Features 8 protein families with glycan shield dynamics tracking for spike proteins.",
  "targets": [
    {
      "name": "IL2_apo",
      "family": "cytokine",
      "description": "Human Interleukin-2 (apo form) - classic cryptic groove target",
      "apo_pdb": "data/calibration/non_spike/1M47.pdb",
      "holo_pdb": "data/calibration/non_spike/1M48.pdb",
      "target_residues": [30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42],
      "core_residues": [15, 16, 17, 18, 19, 20, 85, 86, 87, 88, 89, 90],
      "difficulty": "medium",
      "expected_sasa_gain": 125.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.0,
      "adjacent_residues": [28, 29, 43, 44, 45],
      "mechanism": "induced_fit",
      "known_binders": ["SP4206", "compound_7"]
    },
    {
      "name": "IL2_holo",
      "family": "cytokine",
      "description": "Human IL-2 with small molecule inhibitor - cryptic groove exposed",
      "apo_pdb": "data/calibration/non_spike/1M48.pdb",
      "holo_pdb": "data/calibration/non_spike/1M48.pdb",
      "target_residues": [30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42],
      "core_residues": [15, 16, 17, 18, 19, 20, 85, 86, 87, 88, 89, 90],
      "difficulty": "easy",
      "expected_sasa_gain": 0.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 0.5,
      "adjacent_residues": [28, 29, 43, 44, 45],
      "mechanism": "induced_fit",
      "known_binders": ["SP4206"]
    },
    {
      "name": "PTP1B_apo",
      "family": "phosphatase",
      "description": "Human Protein Tyrosine Phosphatase 1B (apo form) - allosteric site closed",
      "apo_pdb": "data/calibration/non_spike/2HNP.pdb",
      "holo_pdb": "data/calibration/non_spike/1T49.pdb",
      "target_residues": [280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290],
      "core_residues": [45, 46, 47, 48, 49, 50, 215, 216, 217, 218, 219, 220],
      "difficulty": "hard",
      "expected_sasa_gain": 180.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 2.0,
      "adjacent_residues": [275, 276, 277, 278, 279, 291, 292, 293],
      "mechanism": "allosteric",
      "known_binders": ["BB3", "MSI-1436"]
    },
    {
      "name": "PTP1B_holo",
      "family": "phosphatase",
      "description": "Human PTP1B with allosteric inhibitor - allosteric site exposed",
      "apo_pdb": "data/calibration/non_spike/1T49.pdb",
      "holo_pdb": "data/calibration/non_spike/1T49.pdb",
      "target_residues": [280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290],
      "core_residues": [45, 46, 47, 48, 49, 50, 215, 216, 217, 218, 219, 220],
      "difficulty": "medium",
      "expected_sasa_gain": 0.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.0,
      "adjacent_residues": [275, 276, 277, 278, 279, 291, 292, 293],
      "mechanism": "allosteric",
      "known_binders": ["BB3"]
    },
    {
      "name": "KRAS_SOS_pocket",
      "family": "gtpase",
      "description": "KRAS with SOS-inhibiting ligand bound to distinct pocket",
      "apo_pdb": "data/calibration/non_spike/4DSO.pdb",
      "holo_pdb": "data/calibration/non_spike/4DSO.pdb",
      "target_residues": [12, 13, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70],
      "core_residues": [10, 11, 14, 15, 117, 118, 119, 120, 121, 122],
      "difficulty": "hard",
      "expected_sasa_gain": 95.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 3.0,
      "adjacent_residues": [58, 59, 71, 72, 73, 74, 75],
      "mechanism": "allosteric",
      "known_binders": ["sotorasib", "adagrasib"]
    },
    {
      "name": "KRAS_GDP_apo",
      "family": "gtpase",
      "description": "KRAS wild-type GDP-bound (apo form) - Switch II pocket closed",
      "apo_pdb": "data/calibration/non_spike/4LPK.pdb",
      "holo_pdb": "data/calibration/non_spike/5V71.pdb",
      "target_residues": [60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72],
      "core_residues": [10, 11, 12, 13, 14, 15, 117, 118, 119, 120, 121, 122],
      "difficulty": "medium",
      "expected_sasa_gain": 110.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 2.5,
      "adjacent_residues": [57, 58, 59, 73, 74, 75, 76, 77],
      "mechanism": "allosteric",
      "known_binders": ["sotorasib"]
    },
    {
      "name": "KRAS_G12C_SWIIP",
      "family": "gtpase",
      "description": "KRAS G12C mutant with Switch II pocket binder (holo form)",
      "apo_pdb": "data/calibration/non_spike/5V71.pdb",
      "holo_pdb": "data/calibration/non_spike/5V71.pdb",
      "target_residues": [60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72],
      "core_residues": [10, 11, 12, 13, 14, 15, 117, 118, 119, 120, 121, 122],
      "difficulty": "easy",
      "expected_sasa_gain": 0.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.0,
      "adjacent_residues": [57, 58, 59, 73, 74, 75],
      "mechanism": "allosteric",
      "known_binders": ["ARS-1620"]
    },
    {
      "name": "Spike_Closed",
      "family": "viral_glycoprotein",
      "description": "SARS-CoV-2 spike ectodomain CLOSED state - all RBDs down, glycan shield intact",
      "apo_pdb": "data/calibration/spike/6VXX.pdb",
      "holo_pdb": "data/calibration/spike/6VYB.pdb",
      "target_residues": [369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 384, 385],
      "core_residues": [330, 331, 332, 333, 334, 335, 520, 521, 522, 523, 524, 525, 570, 571, 572, 573],
      "difficulty": "hard",
      "expected_sasa_gain": 150.0,
      "is_multimer": true,
      "has_glycans": true,
      "glycan_residues": [61, 122, 149, 165, 234, 282, 331, 343, 603, 616, 657, 709, 717, 801, 1074, 1098, 1134, 1158, 1173, 1194],
      "site_value": 5.0,
      "adjacent_residues": [364, 365, 366, 367, 368, 386, 387, 388, 389, 390, 391, 392],
      "mechanism": "glycan_shield",
      "known_binders": ["S309", "CR3022", "B38", "CB6"]
    },
    {
      "name": "Spike_Open",
      "family": "viral_glycoprotein",
      "description": "SARS-CoV-2 spike ectodomain OPEN state - one RBD up, partial glycan displacement",
      "apo_pdb": "data/calibration/spike/6VYB.pdb",
      "holo_pdb": "data/calibration/spike/6VYB.pdb",
      "target_residues": [369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 384, 385],
      "core_residues": [330, 331, 332, 333, 334, 335, 520, 521, 522, 523, 524, 525, 570, 571, 572, 573],
      "difficulty": "medium",
      "expected_sasa_gain": 0.0,
      "is_multimer": true,
      "has_glycans": true,
      "glycan_residues": [61, 122, 149, 165, 234, 282, 331, 343, 603, 616, 657, 709, 717, 801, 1074, 1098, 1134, 1158, 1173, 1194],
      "site_value": 3.0,
      "adjacent_residues": [364, 365, 366, 367, 368, 386, 387, 388, 389, 390],
      "mechanism": "glycan_shield",
      "known_binders": ["ACE2", "S309"]
    },
    {
      "name": "Spike_S309_Ab",
      "family": "viral_glycoprotein",
      "description": "SARS-CoV-2 spike with S309 neutralizing antibody - cryptic epitope exposed by glycan displacement",
      "apo_pdb": "data/calibration/spike/6WPT.pdb",
      "holo_pdb": "data/calibration/spike/6WPT.pdb",
      "target_residues": [333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345],
      "core_residues": [400, 401, 402, 403, 404, 405, 500, 501, 502, 503, 504, 505],
      "difficulty": "easy",
      "expected_sasa_gain": 0.0,
      "is_multimer": true,
      "has_glycans": true,
      "glycan_residues": [331, 343],
      "site_value": 4.0,
      "adjacent_residues": [330, 331, 332, 346, 347, 348, 349, 350],
      "mechanism": "glycan_shield",
      "known_binders": ["S309", "sotrovimab"]
    },
    {
      "name": "RBD_Neutralizing",
      "family": "viral_glycoprotein",
      "description": "SARS-CoV-2 RBD fragment with REGN antibody cocktail",
      "apo_pdb": "data/calibration/spike/6XDG.pdb",
      "holo_pdb": "data/calibration/spike/6XDG.pdb",
      "target_residues": [417, 453, 455, 456, 475, 476, 477, 478, 484, 485, 486, 487, 489, 493],
      "core_residues": [350, 351, 352, 353, 354, 355, 450, 451, 452, 453, 454, 455],
      "difficulty": "medium",
      "expected_sasa_gain": 0.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 3.5,
      "adjacent_residues": [415, 416, 418, 419, 454, 457, 458, 488, 490, 491, 492, 494],
      "mechanism": "induced_fit",
      "known_binders": ["REGN10933", "REGN10987", "casirivimab", "imdevimab"]
    },
    {
      "name": "Nipah_G_apo",
      "family": "viral_glycoprotein",
      "description": "Nipah virus G attachment glycoprotein - paramyxovirus glycan-shielded epitopes",
      "apo_pdb": "data/raw/2VWD.pdb",
      "holo_pdb": "data/raw/3D11.pdb",
      "target_residues": [236, 237, 238, 239, 240, 241, 242, 507, 508, 509, 510, 511, 512],
      "core_residues": [180, 181, 182, 183, 184, 185, 450, 451, 452, 453, 454, 455],
      "difficulty": "hard",
      "expected_sasa_gain": 120.0,
      "is_multimer": true,
      "has_glycans": true,
      "glycan_residues": [159, 178, 306, 378, 417, 481, 529],
      "site_value": 4.0,
      "adjacent_residues": [233, 234, 235, 243, 244, 245, 505, 506, 513, 514],
      "mechanism": "glycan_shield",
      "known_binders": ["m102.4", "HENV-26", "HENV-32"]
    },
    {
      "name": "p38_kinase_apo",
      "family": "kinase",
      "description": "p38alpha MAP kinase apo form - allosteric back pocket closed",
      "apo_pdb": "data/calibration/expansion/3GCS.pdb",
      "holo_pdb": "data/calibration/expansion/1A9U.pdb",
      "target_residues": [106, 107, 108, 109, 110, 167, 168, 169, 170, 171],
      "core_residues": [30, 31, 32, 33, 34, 35, 145, 146, 147, 148, 149, 150],
      "difficulty": "hard",
      "expected_sasa_gain": 140.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 2.0,
      "adjacent_residues": [103, 104, 105, 111, 112, 164, 165, 166, 172, 173],
      "mechanism": "allosteric",
      "known_binders": ["SB203580", "SB202190", "VX-702"]
    },
    {
      "name": "p38_kinase_holo",
      "family": "kinase",
      "description": "p38alpha MAP kinase with SB203580 inhibitor - back pocket open",
      "apo_pdb": "data/calibration/expansion/1A9U.pdb",
      "holo_pdb": "data/calibration/expansion/1A9U.pdb",
      "target_residues": [106, 107, 108, 109, 110, 167, 168, 169, 170, 171],
      "core_residues": [30, 31, 32, 33, 34, 35, 145, 146, 147, 148, 149, 150],
      "difficulty": "medium",
      "expected_sasa_gain": 0.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.0,
      "adjacent_residues": [103, 104, 105, 111, 112],
      "mechanism": "allosteric",
      "known_binders": ["SB203580"]
    },
    {
      "name": "HSP90_apo",
      "family": "chaperone",
      "description": "HSP90 N-terminal domain apo form - ATP lid closed cryptic site",
      "apo_pdb": "data/calibration/expansion/1YET.pdb",
      "holo_pdb": "data/calibration/expansion/2VCI.pdb",
      "target_residues": [100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110],
      "core_residues": [40, 41, 42, 43, 44, 45, 150, 151, 152, 153, 154, 155],
      "difficulty": "hard",
      "expected_sasa_gain": 130.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 2.5,
      "adjacent_residues": [95, 96, 97, 98, 99, 111, 112, 113, 114, 115],
      "mechanism": "allosteric",
      "known_binders": ["geldanamycin", "17-AAG", "AUY922"]
    },
    {
      "name": "HSP90_holo",
      "family": "chaperone",
      "description": "HSP90 with geldanamycin - ATP lid partially open",
      "apo_pdb": "data/calibration/expansion/2VCI.pdb",
      "holo_pdb": "data/calibration/expansion/2VCI.pdb",
      "target_residues": [100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110],
      "core_residues": [40, 41, 42, 43, 44, 45, 150, 151, 152, 153, 154, 155],
      "difficulty": "medium",
      "expected_sasa_gain": 0.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.0,
      "adjacent_residues": [95, 96, 97, 98, 99, 111, 112],
      "mechanism": "allosteric",
      "known_binders": ["geldanamycin"]
    },
    {
      "name": "HIV_protease_apo",
      "family": "protease",
      "description": "HIV-1 protease apo form - flaps closed cryptic pocket",
      "apo_pdb": "data/calibration/expansion/1HHP.pdb",
      "holo_pdb": "data/calibration/expansion/1HVR.pdb",
      "target_residues": [45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55],
      "core_residues": [25, 26, 27, 28, 29, 30, 80, 81, 82, 83, 84, 85],
      "difficulty": "hard",
      "expected_sasa_gain": 100.0,
      "is_multimer": true,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 2.0,
      "adjacent_residues": [42, 43, 44, 56, 57, 58, 59],
      "mechanism": "flap",
      "known_binders": ["saquinavir", "ritonavir", "indinavir", "darunavir"]
    },
    {
      "name": "HIV_protease_holo",
      "family": "protease",
      "description": "HIV-1 protease with inhibitor - flaps open",
      "apo_pdb": "data/calibration/expansion/1HVR.pdb",
      "holo_pdb": "data/calibration/expansion/1HVR.pdb",
      "target_residues": [45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55],
      "core_residues": [25, 26, 27, 28, 29, 30, 80, 81, 82, 83, 84, 85],
      "difficulty": "medium",
      "expected_sasa_gain": 0.0,
      "is_multimer": true,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.0,
      "adjacent_residues": [42, 43, 44, 56, 57, 58],
      "mechanism": "flap",
      "known_binders": ["inhibitor_bound"]
    },
    {
      "name": "HIV_protease_MDR",
      "family": "protease",
      "description": "HIV-1 protease multi-drug resistant - altered flap dynamics (EXPERT)",
      "apo_pdb": "data/calibration/expansion/2PC0.pdb",
      "holo_pdb": "data/calibration/expansion/2PC0.pdb",
      "target_residues": [45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55],
      "core_residues": [25, 26, 27, 28, 29, 30, 80, 81, 82, 83, 84, 85],
      "difficulty": "expert",
      "expected_sasa_gain": 85.0,
      "is_multimer": true,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 3.0,
      "adjacent_residues": [40, 41, 42, 43, 44, 56, 57, 58, 59, 60],
      "mechanism": "flap",
      "known_binders": ["darunavir"]
    },
    {
      "name": "TEM1_apo",
      "family": "enzyme",
      "description": "TEM-1 beta-lactamase apo form - omega loop closed",
      "apo_pdb": "data/calibration/expansion/1BTL.pdb",
      "holo_pdb": "data/calibration/expansion/1TEM.pdb",
      "target_residues": [162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172],
      "core_residues": [60, 61, 62, 63, 64, 65, 230, 231, 232, 233, 234, 235],
      "difficulty": "medium",
      "expected_sasa_gain": 90.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 1.5,
      "adjacent_residues": [158, 159, 160, 161, 173, 174, 175, 176],
      "mechanism": "loop",
      "known_binders": ["clavulanic_acid", "sulbactam", "tazobactam"]
    },
    {
      "name": "BRAF_V600E_expert",
      "family": "kinase",
      "description": "BRAF V600E mutant - DFG-out cryptic pocket (EXPERT stress test)",
      "apo_pdb": "data/calibration/expansion/3P0G.pdb",
      "holo_pdb": "data/calibration/expansion/4MNE.pdb",
      "target_residues": [594, 595, 596, 597, 598, 599, 600, 601, 602, 603, 604],
      "core_residues": [460, 461, 462, 463, 464, 465, 520, 521, 522, 523, 524, 525],
      "difficulty": "expert",
      "expected_sasa_gain": 160.0,
      "is_multimer": false,
      "has_glycans": false,
      "glycan_residues": [],
      "site_value": 4.0,
      "adjacent_residues": [590, 591, 592, 593, 605, 606, 607, 608, 609, 610],
      "mechanism": "allosteric",
      "known_binders": ["vemurafenib", "dabrafenib", "encorafenib"]
    }
  ],
  "training_parameters": {
    "learning_rate": 0.0001,
    "batch_size": 32,
    "gamma": 0.99,
    "epsilon_start": 1.0,
    "epsilon_end": 0.05,
    "epsilon_decay": 0.995,
    "reward_weighting": {
      "exposure_weight": 10.0,
      "rmsd_weight": 5.0,
      "stability_threshold": 2.5,
      "target_bonus": 50.0,
      "clash_penalty": 1.0,
      "clash_distance": 1.5,
      "glycan_discovery_bonus": 25.0,
      "glycan_displacement_threshold": 3.0,
      "site_value_weight": 1.0,
      "adjacent_bonus": 2.0
    }
  },
  "physics_parameter_ranges": {
    "temperature": [0.1, 5.0],
    "friction": [0.01, 1.0],
    "spring_k": [0.1, 15.0],
    "bias_strength": [0.0, 2.0]
  },
  "macro_step_config": {
    "num_macro_steps": 10,
    "steps_per_macro": 100000,
    "allow_action_change": true,
    "macro_gamma": 0.95
  },
  "feature_config": {
    "neighbor_cutoff": 8.0,
    "contact_cutoff": 6.0,
    "include_global": true,
    "include_target_neighborhood": true,
    "include_stability": true,
    "include_family_flags": true,
    "include_temporal": true,
    "include_difficulty": true,
    "include_glycan_awareness": true,
    "include_mechanism": true,
    "include_bio_chemistry": true,
    "use_gpu_features": true
  },
  "meta_learning_notes": {
    "glycan_shield_insight": "Discovered from 6VXX relaxation: glycan displacement correlates with cryptic site exposure. When glycans move 3+ Angstroms away from target residues AND exposure increases, it indicates biologically meaningful opening rather than destabilization.",
    "site_value_rationale": {
      "5.0": "High-value vaccine/therapeutic targets (spike closed state)",
      "4.0": "Important neutralizing epitopes (spike antibody sites, Nipah, BRAF)",
      "3.0-3.5": "Validated drug targets (KRAS, spike open)",
      "2.0-2.5": "Clinically relevant allosteric sites (PTP1B, p38, HSP90)",
      "1.0-1.5": "Standard targets, holo conformations",
      "0.5": "Control/easy targets for baseline learning"
    },
    "mechanism_strategies": {
      "glycan_shield": "Prioritize glycan displacement tracking, reward correlated exposure",
      "allosteric": "Look for distant site coupling, hinge motions, subtle conformational changes",
      "induced_fit": "Focus on ligand-binding pocket reshaping, local flexibility",
      "flap": "Track flap opening dynamics (HIV protease-style)",
      "loop": "Monitor omega-loop and similar flexible loop movements"
    },
    "feature_dimensions": {
      "base": 23,
      "with_difficulty": 27,
      "with_glycan_awareness": 31,
      "with_mechanism": 37,
      "with_bio_chemistry": 40,
      "full_atomic_aware": 40
    },
    "bio_chemistry_features": {
      "hydrophobic_exposure": "The 'Grease Signal' - SASA weighted by Kyte-Doolittle hydrophobicity. High values indicate exposed oily residues - prime drug targets. ILE=1.0, PHE=0.94, LEU=0.97 (most druggable when exposed).",
      "anisotropy": "The 'Hinge Signal' - Local displacement differential between CÎ± and its neighbors. High values detect mechanical hinges that mark cryptic pocket entrances.",
      "frustration": "The 'Spring Signal' - Coulombic repulsion from like-charges forced close together. High values indicate thermodynamically stressed regions that want to pop open.",
      "snn_mapping": {
        "hydrophobic": "Excitatory neurons - high grease exposure predicts reward",
        "anisotropy": "Pattern recognition - locates the door to cryptic sites",
        "frustration": "Gain modulation - increases sensitivity to movement"
      }
    }
  },
  "expansion_notes": {
    "families": ["cytokine", "phosphatase", "gtpase", "viral_glycoprotein", "kinase", "chaperone", "protease", "enzyme"],
    "difficulty_distribution": {
      "easy": 4,
      "medium": 10,
      "hard": 6,
      "expert": 2
    },
    "total_targets": 22,
    "glycan_targets": 5,
    "high_value_targets": 8,
    "new_in_v311_meta": [
      "Glycan-aware feature extraction (4 dims: proximity, displacement, coverage, correlation)",
      "Mechanism-specific one-hot encoding (6 dims: glycan_shield, allosteric, induced_fit, flap, loop, unknown)",
      "Site value weighting for reward prioritization",
      "Adjacent residue bonus for partial discovery detection",
      "Glycan discovery bonus when displacement correlates with exposure",
      "Enhanced macro-step reward function with all meta-learning components",
      "Glycan residue tracking in spike proteins (N61, N122, N165, N234, N331, N343, etc.)",
      "Known binders metadata for validation context"
    ],
    "holdout_excluded": ["6W41", "1YCR", "2W3L"]
  }
}
